Natco Pharma Limited has applied to the Central Drugs Standard Control Organization (CDSCO) in India for approval of Phase-III clinical trial of Molnupiravir Capsules for the treatment of COVID-19 positive patients.

Syngene International, an integrated research, development and manufacturing services company, announced that it has extended its ongoing research collaboration with Bristol Myers Squibb. The collaboration has been extended through the end of 2030 and will expand the breadth of drug discovery research conducted, including chemistry, biology, drug metabolism and pharmacokinetics, as well as translational medicine research and pharmaceutical development, including chemical process development and analytical sciences, in the coming years.

Walk in Interview (Novel Corona Virus (Covid - 19) It is therefore announced that, in order to meet the status of Novel Corona Virus (Covid 19), management of Anand District Hospitals and Covid Care Centers and treatment of Corona Virus sufferers below.  The said posts have to be filled for three months with fixed honorarium.

Post : Junior Pharmacist

The Tata Memorial Centre (TMC) is a Comprehensive Cancer Centre with a mission to achieve the highest standards in patient care, cancer prevention, cancer research and professional development for oncology and allied disciplines. TMC is an autonomous body funded, controlled by the Department of Atomic Energy, Government of India.

Northern Railway, the Jewel Set in the Crown of Indian Railways, has embarked on the mission to vanquish distances and create its own metaphor of existence. Formally established in the year 1952, it remains the largest zone in terms of route Kilometers, even after the re-organization of the Indian Railways into 16 zones. Northern Railway now comprises of 5 Divisions-Ambala, Delhi, Ferozpur, Lucknow and Moradabad.

National Institute of Malaria Research (NIMR) was established in 1977 as ‘Malaria Research Centre’, which was renamed as ‘National Institute of Malaria Research’ in November 2005. NIMR is one of the institutes of the Indian Council of Medical Research (an autonomous body under Department of Health Research, Ministry of Health & Family Welfare, Govt. of India).

National Institute of Biomedical Genomics (NIBMG) Kalyani is an Institute of Government of India, Ministry of Science & Technology, Department of Biotechnology. The Institute has created necessary physical infrastructure and critical platform technologies to support research, translation and training in biomedical genomics.

Ipca has been partnering healthcare globally in over 110 countries and in markets as diverse as Africa, Asia, Australia, Europe and the US. Ipca is a fully-integrated Indian pharmaceutical company manufacturing over 350 formulations and 80 APIs for various therapeutic segments.

Shilpa Medicare Limited (SML) started its operations as API manufacturer way back in 1987 at Raichur, Karnataka- India. The commercial production in the SML was started in November 1989. Today Shilpa Medicare Limited is a global brand in manufacturing and supplying of affordable API and Formulation globally in different regulated markets.

Emcure Pharmaceuticals Private Limited on April 16, 1981 as a private limited company under the Companies Act, 1956. Our name embodies our purpose and core belief of the entire company which is to make Effective Medicine to Cure patients for enabling them to lead healthier lives.

A synthetic DNA vaccine candidate for Middle East respiratory syndrome coronavirus  MERS-CoV developed at The Wistar Institute induced potent immune responses and afforded protective efficacy in non-human primate models when given intradermally in abbreviated, low-dose immunization regimen. A similar vaccine candidate was previously shown to be safe and tolerable with a three-dose intramuscular injection regimen in a recently completed human phase 1 study and is currently in expanded studies of phase 1/2a trial.

LEO Pharma A/S, a global leader in medical dermatology announced that the Committee for Medicinal Products for Human Use  of the European Medicines Agency (EMA) has adopted a positive opinion and recommended granting a marketing authorization of Adtralza (tralokinumab) for the treatment of moderate-to-severe atopic dermatitis in adult patients who are candidates for systemic therapy.

US-India Strategic Partnership Forum and members appreciate the efforts by leaders across the U.S. government at the highest level to identify concrete steps the United States can take to assist India through this crisis. The company looks forward to announcements soon that will support India’s efforts to fill needs like oxygen, medicines, medical supplies, and vaccines. This should include a waiver of current restrictions on the export of vaccine raw materials to ensure production of vaccine in India can continue uninterrupted.

Biocon Biologics Ltd., a subsidiary of Biocon Ltd has announced that Abevmy 100 and 400 mg, a biosimilar of Bevacizumab co-developed with Viatris Inc. has received marketing authorization approval from the European Commission following the positive recommendation by the Committee for Medicinal Products for Human Use of the European Medicines Agency.

South Central Railway was formed on 02.10.1966 when Hubli and Vijayawada Divisions of Southern Railway and Sholapur and Secunderabad Divisions of Central Railway were carved out and merged into a new Zone. Subsequently, Guntakal Division of Southern Railway was merged with South Central Railway on 02.10.1977 and Sholapur Division was remerged with Central Railway. Secunderabad Division was split into two Divisions viz. Secunderabad and Hyderabad on 17.02.1978.

Indian Institute of Technology Guwahati, the sixth member of the IIT fraternity, was established in 1994. The academic programme of IIT Guwahati commenced in 1995. At present the Institute has eleven departments and five inter-disciplinary academic centres covering all the major engineering, science and humanities disciplines, offering BTech, BDes, MA, MDes, MTech, MSc and PhD programmes.

Sanjay College of Pharmacy, Mathura established in the year 2007. The Institute offers, full time four-year degree course in Pharmacy (B.Pharm) and Two years (D.Pharm). The institute is located in a peaceful & Pollution free environment, which has an attractive building comprising of administrative block, Lecture halls, laboratories, Library, Medicinal garden, Lush green lawns & play grounds.

Centre for Development of Advanced Computing (C-DAC), is a scientific society of the Department of Information Technology under the Ministry of Communications and Information Technology, Government of India. C-DAC has today emerged as a premier R&D organization in ICT&E (Information, Communications Technologies and Electronics) in the country, working on strengthening national technological capabilities in the context of global developments in the field and responding to change in the market need in selected foundation areas.

The Rajiv Gandhi Centre for Biotechnology (RGCB) is an autonomous national institute of the Government of India, Ministry for Science & Technology, Department of Biotechnology. The mandate of the institute is discovery, innovation and translation in biotechnology and disease biology. At RGCB, our todays are committed to making discoveries that lead to a better tomorrow. RGCB prides itself for innovative research that integrates theory, modeling, simulation, experimental translational and clinical sciences.